Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dow Inc (DOW) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance

Ionis Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Dow Inc vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Dow Inc trades at $29.36 (market cap $20.59B), while Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B). The key difference: Dow Inc is far larger — about 2.9× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Dow Inc pays a 4.91% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dow Inc for 83 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.

DOWIONS
Market Cap
$20.59B$7.04B
Volume
5,540,7462,977,440
Sector
Basic MaterialsHealth
52-Week High
$41.87$86.50
52-Week Low
$20.95$42.38
Typical Hold Time
83 Days0 Days
Enterprise Value
$36.29B$6.60B
Dividend Yield
4.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dow Inc

DOW trades at $29.19, up 3.81% on the day, with a bearish technical signal and neutral oscillators. The company reported negative net income of -$2.62B in 2025, with declining revenue from $56.9B in 2022 to $40.0B in 2025. Recent earnings have beaten expectations, but profitability metrics like ROE (-7.86%) and net margin (-3.13%) remain weak. Analyst consensus is a $33.80 price target with mixed ratings (30.56% Buy, 55.56% Hold).

The outlook is cautious due to persistent margin pressures and high debt levels, though the dividend payout and earnings beats offer some stability. Risks include cyclical demand weakness and rising leverage, but the stock trades below consensus target, suggesting potential upside if operational improvements materialize.

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DOW
0% Buy100% Sell
Avg holding period · 83 Days
IONS
100% Buy0% Sell
Avg holding period · 0 Days

About Dow Inc

Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.

Read more on DOW →

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →